Bio-Path Holdings (BPTH) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

BPTH is expected to report earnings to rise 1,587.50% to -540 cents per share on March 08

Bio-Path Holdings BPTH Stock Earnings Reports

Q4'23

Est.

$-5.40

Q3'23

Beat

by $0.02

Q2'23

Missed

by $0.09

Q1'23

Missed

by $0.20

Q4'22

Missed

by $1.44

The last earnings report on November 15 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 51.41K shares outstanding, the current market capitalization sits at 2.51M.

View a ticker or compare two or three

Compare

BPTH

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BPTH
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical stage biotechnology company, which focuses on developing therapeutic products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

4710 Bellaire Boulevard

Phone

+1 832 742-1357

Employees

Web

https://www.biopathholdings.com